M S Carey

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi RPPAML/RIMS: a metadata format and an information management system for reverse phase protein arrays
    Romesh Stanislaus
    Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    BMC Bioinformatics 9:555. 2008
  2. ncbi The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer
    M S Carey
    National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada
    Gynecol Oncol 108:100-5. 2008
  3. ncbi Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?
    J S Kwon
    Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas 77230 1439, USA
    Int J Gynecol Cancer 18:820-4. 2008
  4. ncbi Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants
    F Lackman
    Division of Gynecologic Oncology, London Health Sciences Centre, London, Ontario, Canada
    Gynecol Oncol 90:407-12. 2003
  5. ncbi Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback
    G P Browman
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    J Clin Oncol 16:1226-31. 1998
  6. ncbi Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study
    J S Kwon
    Division of Gynecologic Oncology, University of Western Ontario, London, Ontario, Canada
    Int J Gynecol Cancer 17:433-40. 2007

Collaborators

Detail Information

Publications6

  1. ncbi RPPAML/RIMS: a metadata format and an information management system for reverse phase protein arrays
    Romesh Stanislaus
    Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    BMC Bioinformatics 9:555. 2008
    ..Up to 100 different proteins may be assessed using immunoperoxidase or immunoflorescence techniques in order to determine relative amounts of protein expression in the samples of interest...
  2. ncbi The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer
    M S Carey
    National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada
    Gynecol Oncol 108:100-5. 2008
    ..The purpose of this study was to evaluate the prognostic significance of PS and quality of life (QoL) assessment on progression-free survival (PFS) and overall survival (OS) in patients with advanced ovarian cancer...
  3. ncbi Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?
    J S Kwon
    Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas 77230 1439, USA
    Int J Gynecol Cancer 18:820-4. 2008
    ..Further prospective evaluation of different adjuvant therapy practices is required for early-stage UPSC and CCC, which may be useful in the design of future clinical trials...
  4. ncbi Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants
    F Lackman
    Division of Gynecologic Oncology, London Health Sciences Centre, London, Ontario, Canada
    Gynecol Oncol 90:407-12. 2003
    ..CONCLUSIONS: Carefully staged patients with advanced serous borderline tumors of the ovary and noninvasive implants have a good prognosis without adjuvant therapy...
  5. ncbi Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback
    G P Browman
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    J Clin Oncol 16:1226-31. 1998
    ....
  6. ncbi Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study
    J S Kwon
    Division of Gynecologic Oncology, University of Western Ontario, London, Ontario, Canada
    Int J Gynecol Cancer 17:433-40. 2007
    ..In this population-based study, there were variable patterns of practice for intermediate- and high-risk stage I and II endometrial cancer. Surgical staging and APRT did not affect OS...